VAXINE PTY LTD

Hepatitis B, a significant global health challenge, is expected to see market growth due to increasing prevalence and awareness. Key companies like Gilead Sciences and Brii Biosciences are advancing treatments through clinical trials. The market, driven by antiviral medications, anticipates a surge with new pipeline products. Vaccination remains the most effective prevention method.